Company / Cash per Share
Prime Medicine, Inc. Cash per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.54
FY2024
5-year range
$0.46 / $14.29
FY2020-FY2024
Trend
+236.7%
vs FY2023
Sector context
#117 of 203
Health Care
What the data says
Cash per Share changed +237% YoY in FY2024, a notable deviation from the 4-year average annual change of +21%.
Based on SEC 10-K filings.
1.54 in FY2024 with a 3-year CAGR of -52.4%.
Declined from $5.54 to $1.54 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -52.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#117 of 203 in Health CareTop 58% of 203This company $1.54 Sector average $76.43
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2024, cash per share increased 236.7% year-over-year.
- Ranks #117 out of 203 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.54 | +236.7% |
| FY2023 | $0.46 | -91.7% |
| FY2022 | $5.54 | -61.3% |
| FY2021 | $14.29 | +2.0% |
| FY2020 | $14.01 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026